Skyscape Web Viewer : Cancer Pharmacology: An Illustrated Manual of Anticancer Drugs : Main Index

View All
CAA
capillary leak syndrome (CLS)
cardiac repolarization (QTc)
CAR-T
castration-resistant prostate cancer (CRPC) Question 10.2 Male Hormonal Therapies
CDC
CDK inhibitors cell cycle and transcription antiapoptotic proteins
central nervous system (CNS) Answer 11.1 Anticancer Drug Development: An Introduction Answer 2.2
cerebrospinal fluid (CSF) Transplant-Related Agents Anticancer Drug Development: An Introduction
checkpoint inhibitors (CPIs) anti-tumor immunity multiple cancers management immune-related adverse effects Multiple Myeloma as a Paradigm for Multi-Targeted Intervention
checkpoint kinase 1 (CHK1)
chimeric antigen receptor (CAR) Multiple Myeloma as a Paradigm for Multi-Targeted Intervention Immunotherapeutics Including Vaccines, Bispecifics, CAR-T, and Checkpoint Inhibitors T-cell therapy
CHK1
chloroacetaldehyde (CAA)
chronic lymphocytic leukemia (CLL) Antimetabolites: Hydroxyurea, Pyrimidine and Purine Analogs, and L-Asparaginase Question 3.1 DNA Repair, Apoptotic Pathways, CDK Inhibitors Targeted Therapies (Small Molecules)
chronic myeloid leukemia (CML)
cladribine, cytarabine, and filgrastim with mitoxantrone (CLAG-M) Answer 3.2 Question 3.7
CLAG-M
Clinical trials
CLS
CML
CNS
Common Terminology Criteria for Adverse Events (CTCAE)
complement-mediated cellular cytotoxicity (CDC)
CAP
CAR
carmustine (BCNU)
CDA
CDKs
cGVHD